Medtronic Prostiva RF Therapy Generator. The Prostiva RF system is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men over the age of 50 with prostate sizes between 20 and 50 cm3.
Publicado el 10 de abril de 2013 · Inicio del retiro: 27 de febrero de 2013
Resumen
FDA registra el retiro Z-1031-2013 de dispositivos médicos de Clase II, publicado el 10 de abril de 2013 e iniciado el 27 de febrero de 2013. Empresa responsable: Medtronic Neuromodulation; Estado: Finalizado; Cantidad reportada: 848 (696 US, 152 OUS); Lote: all Model 8930 radio frequency (RF) generators are affected. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Medtronic has found through device testing that if the optional footswitch is not connected to the Model 8930 RF generator during use, an electrostatic discharge (i.e. static electricity) to the footswitch connector port may toggle the RF output on or off. If this were to occur, it could result in unintentionally starting or stopping the lesion process, depending on the current status of the equi
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Medtronic Neuromodulation
- Distribuidor
- Nationwide Distribution including Puerto Rico and all States in continental USA except ID, MT, and NH.
- Lote
- all Model 8930 radio frequency (RF) generators are affected
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAInterStim SureScan MRI Leads 978A1 & 978B1: LEAD 978A128 ISTM MICRO 28CM SSMRI TINED 978A128 LEAD 978A133 ISTM28 de octubre de 2026
- FDAInterStim Percutaneous Extensions EXT 3560022 ISTM II PERC 3560022 EXT 3560030 ISTM MICRO PERC 356003028 de octubre de 2026
- FDAMedtronic 2x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64002; Stimulator, electrical, implanted,3 de junio de 2026
- FDAMedtronic 1x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64001; Stimulator, electrical, implanted,3 de junio de 2026
- FDAIntegra Ojemann Cortical Stimulator; Product / Catalogue No: OCS2. Intended for intraoperative cortical10 de abril de 2013
- FDAAccess Immunoassay System; P/N 107405S Product Usage: The Access Immunoassay Systems are in vitro diagnostic10 de abril de 2013
Preguntas sobre este retiro
¿Medtronic Prostiva RF Therapy Generator. The Prostiva RF system is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men over the age of 50 with prostate sizes between 20 and 50 cm3. fue retirado del mercado?
Sí. FDA publicó el retiro Z-1031-2013 el 10 de abril de 2013. Peligro reportado: Medtronic has found through device testing that if the optional footswitch is not connected to the Model 8930 RF generator during use, an electrostatic discharge (i.e. static electricity) to the footswitch connector port may toggle the RF output on or off. If this were to occur, it could result in unintentionally starting or stopping the lesion process, depending on the current status of the equi
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter